Bluejay Diagnostics, Inc.
BJDX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $893 | $66,886 | $383,011 | $2,574,356 |
| - Cash | $4,302 | $2,209 | $10,115 | $19,048 |
| + Debt | $222 | $353 | $493 | $0 |
| Enterprise Value | -$3,187 | $65,031 | $373,389 | $2,555,309 |
| Revenue | $0 | $0 | $249 | $0 |
| % Growth | – | -100% | – | – |
| Gross Profit | $0 | $0 | $49 | -$146 |
| % Margin | – | – | 19.6% | – |
| EBITDA | -$6,696 | -$9,173 | -$9,011 | -$3,084 |
| % Margin | – | – | -3,618.5% | – |
| Net Income | -$7,718 | -$9,954 | -$9,297 | -$3,730 |
| % Margin | – | – | -3,733.1% | – |
| EPS Diluted | -42.08 | -72.62 | -73.22 | -29.67 |
| % Growth | 42.1% | 0.8% | -146.8% | – |
| Operating Cash Flow | -$7,820 | -$8,314 | -$7,742 | -$4,367 |
| Capital Expenditures | -$307 | -$704 | -$1,199 | -$24 |
| Free Cash Flow | -$8,127 | -$9,018 | -$8,941 | -$4,391 |